Free Live Webinar · Session 4 of 6

AI-Driven Patient Recruitment and Site Selection

Date November 12, 2026
Time11:00 AM ET
FormatPanel, 60 minutes
CostFree, and recorded
What you'll take away
  • See what feasibility and site management teams are getting from AI site scoring, measured against their own historical selections
  • Understand where bias enters site ranking and patient pre-screening, and how to test for it before the model drives decisions
  • Learn how EHR and claims-based patient identification interacts with privacy and consent obligations
  • Discover what to document in the diversity action plan to defend how sites and patients were identified
  • Gain insight into which decisions still belong with a human, and how to record that they were made
  • Hear real-world examples of enrollment outcomes from AI-supported feasibility

Save your seat

Free to attend. Can't join live? Register and we'll send the recording.

Access granted

AI in Clinical Trials: What FDA and EMA Now Expect

Jessica Cordes (Senior Consultant, Clinical Excellence), Saubiya Kidwai (Vice President of Quality Signant Health), Dr. Selena Baset (Founder & CEO, TraceLine Solutions) Recorded live at AI in GxP West
Our Partners

Sponsored By

The panel

Who you'll hear from.

A panel of practitioners who live inside these questions, moderated live with audience Q&A.

Moderator
Jessica Cordes
Senior Consultant
Clinical Excellence
Panelist
Saubiya Kidwai
Vice President of Quality
Signant Health
Panelist
Dr. Selena Baset
Founder & CEO
TraceLine Solutions
Why now

Rethinking Site Selection with AI

Feasibility has always been part data, part relationship, part guesswork. AI now scores sites on historical enrollment and screen-failure performance, and identifies eligible patients from EHR and claims data before the protocol is final. The gains are real, and so is the problem underneath them: a model trained on which sites enrolled well historically will recommend the same sites that produced the trial populations sponsors are now under pressure to move past.

Built for

Who should attend.

Built for the people accountable when AI touches a trial, across quality, data, operations, and regulatory.

Clinical Operations Study Start-up Site management Patient Recruitment Clinical QA GCP Compliance Regulatory Affairs
The series

Part of AI in Clinical Operations & Clinical Trials.

Six live panels on where artificial intelligence is reshaping clinical trials. Free to attend, and every session recorded.

Save your seat.

Thursday, November 12, 2026 11:00 AM  ·  ET  ·  Free to attend

Register free